Diabetes Melletus, Type 1

2

Review clinical trials related to Diabetes Melletus, Type 1. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

The study is a randomized, double-blind, parallel-group clinical trial to examine the effects of 24 weeks of oral AMX0035 (sodium phenylbutyrate + taurursodiol) versus placebo in 60 adults with Type 1 Diabetes (T1D) (n=30 per arm). Enrollment will be distributed equally between the University of Washington and Amsterdam University Medical Center/Diabetes Center Amsterdam. Participants will be recruited through diabetes research registries, local T1D clinics, and community outreach.

Participants needed: 60
Trial details
Phase: Phase 2Age: 18-69Biological sex: AllType: InterventionalSponsor: University of WashingtonUpdated: Jul 13, 2026Locations: 2
Eligibility criteria

Adults ≥18 years to <70 years of age with established T1D (duration ≥1 year) [+5]

History of pancreatic disease (including pancreatitis) or pancreatic surgery [+18]

Status: Recruiting

ROME GS System Study

The purpose of this clinical investigation is to demonstrate that the proposed physical changes to the ROME GS Sensor do not have any adverse impact on safety and performance when compared to the Eversense 365 Sensor.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Senseonics, Inc.Updated: Apr 21, 2026Locations: 4
Eligibility criteria

Subjects ≥18 years of age [+2]

History of unexplained severe hypoglycemia in the previous 6 months. Severe hypo... [+16]